AEON Global Health Corp. (AGHC)

Market Cap	842,780
Revenue (ttm)	12.93M
Net Income (ttm)	-8.32M
Shares Out	8.20M
EPS (ttm)	-1.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	0
Open	0.0900
Previous Close	0.0900
Day's Range	0.0900 - 0.0900
52-Week Range	0.0400 - 0.4400
Beta	-0.46
Analysts	n/a
Price Target	n/a
Est. Earnings Date	n/a

About AGHC

Aeon Global Health Corp., together with its subsidiaries, provides various clinical laboratory testing services in the United States. The company operates through Laboratory Testing Services and Web-Based Software segments. Its laboratory testing services include the testing of an individual's blood, urine, or saliva for the presence of drugs or chemicals, as well as the patient's DNA profile. The company primarily offers medical toxicology, DNA pharmacogenomics, cancer genetic testing, and molecular biology tests. It also provides Web-based se...

• Industry: Health Care Providers & Services
• CEO: Hanif Roshan
• Employees: 52
• Stock Exchange: OTCMKTS
• Ticker Symbol: AGHC

Full Company Profile

Financial Performance

In 2019, AGHC's revenue was $12.93 million, a decrease of -20.67% compared to the previous year's $16.30 million. Losses were -$7.98 million, -0.31% less than in 2018.

Financial Statements

News

There is no news available yet.